back
  
 

ऐप डाउनलोड करें

लॉग इन
Profile
Search

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Uses

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is used to prevent HPV-associated cancers, including genital warts and cervical cancer.

How it Works

How Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Works Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is a vaccine that helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies to protect against future infections.

Side Effects

Common side effects of the Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant include nausea, headache, fever, injection site hematoma, and pain in the extremities.

Expert Advice

  • Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant helps protect against diseases caused by Human Papillomavirus (HPV), such as genital warts and certain types of cancer, including cervical cancer.
  • It does not cure an existing HPV infection but can protect you from other strains of HPV.
  • If you are 9 to 14 years of age, you will receive a 2-dose schedule (0 and 6 months).
  • If you are 15 years or older, you will receive a 3-dose schedule (0, 1, and 6 months).
  • The vaccine is usually administered by injection into the muscle of the upper arm.
  • Remain seated for at least 15 minutes after the injection, as it may cause dizziness or fainting.
  • Inform your doctor if you have a bleeding disorder or if you are taking medications such as high doses of corticosteroids or immunosuppressants.
  • It does not protect against every type of HPV.
  • Take precautions against sexually transmitted diseases and follow your doctor’s advice.
  • It is essential to complete the full vaccination course.
  • If you forget to take a dose, you can resume from where you left off. Consult with your doctor to confirm if you can resume.

Related Medications

Frequently asked questions

The vaccine is safe, well-tolerated, and undergoes extensive testing and monitoring. Common side effects are mild to moderate.
Clinical trials indicate that the vaccine offers nearly 100% protection against cervical and vaginal cancers, as well as genital warts caused by the targeted HPV types.
No, it is not a live vaccine; it contains virus-like particles that cannot cause infection or cancer.
The vaccine is ideally given to adolescent girls aged 11 to 12, and is also recommended for teenagers and adults aged 13 to 26 who missed earlier vaccination. Children as young as 9 can receive it with a doctor's advice.
Yes, the vaccine can still be beneficial even if you've had sexual intercourse, as it protects against multiple HPV strains, including those you may not have been exposed to.
Research suggests long-lasting protection, with studies showing efficacy for at least 12 years, but ongoing research is determining the exact duration.
The vaccine is recommended for girls aged 9 to 13 and can be given to women up to 45 years old; for males, it is recommended for ages 16 to 26.
You can continue from where you left off without restarting the series, but it is advisable to consult your doctor first.
Yes, condoms do not provide complete protection against HPV, as the virus can be transmitted through skin-to-skin contact.
The vaccine generally has mild side effects, such as soreness at the injection site, dizziness, headaches, and fatigue. Serious side effects are rare.
Yes, regular cervical cancer screenings are still necessary, as the vaccine does not protect against all HPV types that can cause cervical cancer.
Yes, the HPV vaccine can be given alongside other vaccines, provided different syringes and injection sites are used. Consult your doctor for guidance.
The vaccine is highly effective against the targeted HPV types, but is less effective for those already exposed to certain HPV strains.
Quadrivalent indicates that the vaccine protects against four types of HPV, specifically types 6, 11, 16, and 18, preventing related diseases but not treating them.
No HPV or Pap tests are needed prior to vaccination, but women should still undergo regular cervical cancer screenings afterwards.
The vaccine is used to prevent cervical, vulvar, and vaginal cancers caused by HPV in females, as well as pre-cancerous lesions and genital warts in both males and females.